ADAR1 Capital Management, LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$1.4B
Holdings
256
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (256 positions)
| Stock | Value |
|---|---|
ABVXABIVAX SA | $177.6M |
PTGXPROTAGONIST THERAPEUTICS INC | $91.6M |
ROIVROIVANT SCIENCES LTD | $74.4M |
IMVTIMMUNOVANT INC | $63.1M |
RNAAVIDITY BIOSCIENCES INC | $39.4M |
BOXXEA SERIES TRUST | $38.8M |
SPYSPDR S&P 500 ETF TR | $37.3M |
CYTKCYTOKINETICS INC | $34.3M |
SEPNSEPTERNA INC | $32.3M |
I9DNARBUTUS BIOPHARMA CORP | $26.0M |
—PERCEPTIVE CAP SOLUTIONS COR | $25.5M |
ZLABZAI LAB LTD | $22.0M |
TERNTERNS PHARMACEUTICALS INC | $21.9M |
CTMXCYTOMX THERAPEUTICS INC | $18.2M |
TCE2CELLDEX THERAPEUTICS INC NEW | $17.6M |
RAPTRAPT THERAPEUTICS INC | $17.3M |
IKTINHIBIKASE THERAPEUTICS INC | $16.5M |
BBIOBRIDGEBIO PHARMA INC | $16.3M |
MNPRMONOPAR THERAPEUTICS INC | $15.3M |
FULCFULCRUM THERAPEUTICS INC | $14.9M |
PCVXVAXCYTE INC | $14.6M |
CRNXCRINETICS PHARMACEUTICALS IN | $14.4M |
PRTAPROTHENA CORP PLC | $13.9M |
LXEOLEXEO THERAPEUTICS INC | $13.8M |
TSHATAYSHA GENE THERAPIES INC | $13.7M |
CDTXCIDARA THERAPEUTICS INC | $13.2M |
IVAINVENTIVA SA | $12.6M |
ESTAESTABLISHMENT LABS HLDGS INC | $12.5M |
BILSPDR SERIES TRUST | $12.4M |
REPLREPLIMUNE GROUP INC | $12.3M |
ISIIONIS PHARMACEUTICALS INC | $11.6M |
RVMDREVOLUTION MEDICINES INC | $11.6M |
AMLXAMYLYX PHARMACEUTICALS INC | $10.8M |
CGONCG ONCOLOGY INC | $10.7M |
YCYAA MISSION ACQUISITION CORP | $10.5M |
TFXTELEFLEX INCORPORATED | $9.8M |
IWMISHARES TR | $9.7M |
IVVDINVIVYD INC | $9.6M |
REGNREGENERON PHARMACEUTICALS | $9.3M |
XENEXENON PHARMACEUTICALS INC | $9.1M |
EQEQUILLIUM INC | $8.7M |
YB4PSAVARA INC | $8.5M |
MAZEMAZE THERAPEUTICS INC | $7.4M |
TEVATEVA PHARMACEUTICAL INDS LTD | $7.4M |
CBIOCRESCENT BIOPHARMA INC. | $7.2M |
OVIDOVID THERAPEUTICS INC | $7.0M |
BLTEBELITE BIO INC | $6.4M |
QUREUNIQURE NV | $6.3M |
VRTXVERTEX PHARMACEUTICALS INC | $6.2M |
BHFBRIGHTHOUSE FINL INC | $6.2M |
AVRANTERIS TECHNOLOGIES GLOBAL | $6.2M |
TARAPROTARA THERAPEUTICS INC | $6.1M |
DHRDANAHER CORPORATION | $5.9M |
CLYMCLIMB BIO INC | $5.7M |
RYTMRHYTHM PHARMACEUTICALS INC | $5.5M |
OACCOAKTREE ACQUISITION CORP III | $5.5M |
ASNDASCENDIS PHARMA A/S | $5.4M |
AGIOAGIOS PHARMACEUTICALS INC | $5.1M |
SPRBSPRUCE BIOSCIENCES INC | $5.1M |
MLYSMINERALYS THERAPEUTICS INC | $4.9M |
KRYSKRYSTAL BIOTECH INC | $4.9M |
PALIPALISADE BIO INC | $4.7M |
SPRYARS PHARMACEUTICALS INC | $4.3M |
BIIBBIOGEN INC | $4.3M |
NAMSNEWAMSTERDAM PHARMA COMPANY | $4.2M |
AEXAAMERICAN EXCEPTIONALISM ACQU | $4.1M |
URGNUROGEN PHARMA LTD | $3.9M |
ARWRARROWHEAD PHARMACEUTICALS IN | $3.9M |
ATAIATAI BECKLEY NV | $3.7M |
CRVSCORVUS PHARMACEUTICALS INC | $3.6M |
JANXJANUX THERAPEUTICS INC | $3.4M |
GLUEMONTE ROSA THERAPEUTICS INC | $3.4M |
AVDLAVADEL PHARMACEUTICALS PLC | $3.2M |
CTNMCONTINEUM THERAPEUTICS INC | $3.2M |
EVMNEVOMMUNE INC | $3.2M |
GUTSFRACTYL HEALTH INC | $3.1M |
SNYSANOFI SA | $3.1M |
SRRKSCHOLAR ROCK HLDG CORP | $3.1M |
NKTRNEKTAR THERAPEUTICS | $3.0M |
ZURAZURA BIO LTD | $2.9M |
OKURONKURE THERAPEUTICS INC | $2.9M |
LONAATHIRA PHARMA INC | $2.9M |
BBOTBRIDGEBIO ONCOLOGY THERAPEUT | $2.8M |
ELDNELEDON PHARMACEUTICALS INC | $2.8M |
ENGNENGENE HOLDINGS INC | $2.7M |
INOINOVIO PHARMACEUTICALS INC | $2.7M |
DVAXDYNAVAX TECHNOLOGIES CORP | $2.6M |
VRDNVIRIDIAN THERAPEUTICS INC | $2.4M |
PHVSPHARVARIS N V | $2.4M |
CRBPCORBUS PHARMACEUTICALS HLDGS | $2.3M |
CATBUSDASTRIA THERAPEUTICS INC | $2.3M |
DCTHDELCATH SYS INC | $2.3M |
EWTXEDGEWISE THERAPEUTICS INC | $2.3M |
GRCEGRACE THERAPEUTICS INC | $2.2M |
GOSSGOSSAMER BIO INC | $2.2M |
RGNXREGENXBIO INC | $2.1M |
ACLXARCELLX INC | $2.1M |
OLMAOLEMA PHARMACEUTICALS INC | $2.0M |
3M4MASIMO CORP | $1.9M |
HELPCYBIN INC | $1.9M |
Page 1 of 3Next